Skip to main content

stock

GRTX · Galera Therapeutics, Inc.

What Galera Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live GRTX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on GRTX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
160,429,783 as of 2026-05-12 (XBRL frame )

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
20471.8%
ROA
2417.8%

Health

Current ratio
—
Debt/equity
—

Deep value

NCAV
$4.92M
NCAV per share
$0.03
Price/NCAV
Locked
NNWC
$4.36M
NNWC per share
$0.03
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-03-31; balance sheet at 2026-03-31.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.66M-$1.61M
10-Q filed 2026-05-14
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.$1.99M$153.10M
DEF 14A filed 2026-04-20
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.44M-$1.39M
10-Q filed 2025-11-13
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.14M-$1.07M
10-Q filed 2025-11-13
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$1.96M-$1.59M
10-Q filed 2026-05-14
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.-$5.47M-$4.93M
DEF 14A filed 2026-04-20
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$5.91M-$5.58M
10-Q filed 2025-11-13
2024-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.-$4.21M-$4.06M
10-Q filed 2025-11-13
Assembled from more than one filing; the filing above is only the newest of them.
Assets
$6.16M
Equity
$728,000

Balance as of 2026-03-31.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$2.54M$149.05M—
2024-12-31—-$20.16M-$18.96M-$12.14M
2023-12-31—-$49.26M-$59.08M-$44.91M
2022-12-31—-$51.23M-$62.22M-$43.45M
2021-12-31—-$73.37M-$80.53M-$68.24M
2020-12-31—-$70.55M-$74.22M-$59.99M
2019-12-31—-$50.69M-$51.93M-$47.29M
2018-12-31—-$24.25M-$23.68M-$22.51M

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named GRTX, and the market events around them.

Sign in to see this

Board

The GRTX board could not be loaded.

Retry the GRTX board

nakagai

Signals on GRTX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the GRTX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Galera Therapeutics, Inc. (GRTX): SEC filings, financials and insider trades · Nakagai